Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release
Cencora (NYSE: COR) has scheduled its Second Quarter Fiscal 2025 earnings release for Wednesday, May 7, 2025, before the NYSE opening. The company will host a conference call at 8:30 a.m. ET featuring CEO Robert P. Mauch and CFO James F. Cleary.
The earnings call will be accessible via webcast on investor.cencora.com and by telephone. U.S. and Canada participants can dial (833) 470-1428, while international callers should use +1 (404) 975-4839, with access code 962235.
Cencora, ranked #10 on Fortune 500 and #18 on Global Fortune 500, generates over $290 billion in annual revenue. The company employs 46,000+ team members globally and focuses on pharmaceutical solutions, partnering with innovators to optimize market access to therapies.
Cencora (NYSE: COR) ha programmato il rilascio dei risultati finanziari del secondo trimestre fiscale 2025 per mercoledì 7 maggio 2025, prima dell'apertura della NYSE. L'azienda ospiterà una conference call alle 8:30 a.m. ET con il CEO Robert P. Mauch e il CFO James F. Cleary.
La chiamata sugli utili sarà accessibile tramite webcast su investor.cencora.com e telefonicamente. I partecipanti degli Stati Uniti e del Canada possono comporre il numero (833) 470-1428, mentre i chiamanti internazionali dovrebbero utilizzare il numero +1 (404) 975-4839, con il codice di accesso 962235.
Cencora, classificata al #10 nella Fortune 500 e al #18 nella Global Fortune 500, genera oltre 290 miliardi di dollari di fatturato annuale. L'azienda impiega oltre 46.000 membri del team a livello globale e si concentra su soluzioni farmaceutiche, collaborando con innovatori per ottimizzare l'accesso al mercato delle terapie.
Cencora (NYSE: COR) ha programado la publicación de sus resultados del segundo trimestre fiscal 2025 para miércoles 7 de mayo de 2025, antes de la apertura de la NYSE. La compañía llevará a cabo una llamada de conferencia a las 8:30 a.m. ET con el CEO Robert P. Mauch y el CFO James F. Cleary.
La llamada de ganancias será accesible a través de un webcast en investor.cencora.com y por teléfono. Los participantes de EE. UU. y Canadá pueden marcar (833) 470-1428, mientras que los llamantes internacionales deben usar +1 (404) 975-4839, con el código de acceso 962235.
Cencora, clasificada en el #10 de la Fortune 500 y en el #18 de la Global Fortune 500, genera más de 290 mil millones de dólares en ingresos anuales. La compañía emplea a más de 46,000 miembros del equipo a nivel mundial y se centra en soluciones farmacéuticas, asociándose con innovadores para optimizar el acceso al mercado de terapias.
Cencora (NYSE: COR)는 2025년 5월 7일 수요일에 NYSE 개장 전 2025 회계연도 2분기 실적 발표를 예정하고 있습니다. 회사는 CEO Robert P. Mauch와 CFO James F. Cleary가 참여하는 오전 8시 30분 ET에 컨퍼런스 콜을 개최합니다.
실적 발표는 investor.cencora.com에서 웹캐스트를 통해 접근할 수 있으며 전화로도 참여할 수 있습니다. 미국 및 캐나다 참가자는 (833) 470-1428로 전화할 수 있으며, 국제 전화자는 +1 (404) 975-4839를 사용해야 하며, 접근 코드 962235를 입력해야 합니다.
Cencora는 Fortune 500에서 10위, Global Fortune 500에서 18위에 랭크되어 있으며, 연간 2,900억 달러 이상의 수익을 창출합니다. 이 회사는 전 세계적으로 46,000명 이상의 팀원을 고용하고 있으며, 혁신가들과 협력하여 치료제의 시장 접근성을 최적화하는 제약 솔루션에 집중하고 있습니다.
Cencora (NYSE: COR) a prévu la publication de ses résultats pour le deuxième trimestre de l'exercice 2025 pour mercredi 7 mai 2025, avant l'ouverture de la NYSE. L'entreprise tiendra une conférence téléphonique à 8h30 ET avec le PDG Robert P. Mauch et le directeur financier James F. Cleary.
La conférence sur les résultats sera accessible via un webcast sur investor.cencora.com et par téléphone. Les participants des États-Unis et du Canada peuvent composer le (833) 470-1428, tandis que les appelants internationaux doivent utiliser le +1 (404) 975-4839, avec le code d'accès 962235.
Cencora, classée au 10e rang du Fortune 500 et au 18e rang du Global Fortune 500, génère plus de 290 milliards de dollars de revenus annuels. L'entreprise emploie plus de 46 000 membres d'équipe à l'échelle mondiale et se concentre sur des solutions pharmaceutiques, en s'associant à des innovateurs pour optimiser l'accès au marché des thérapies.
Cencora (NYSE: COR) hat die Veröffentlichung der Ergebnisse für das zweite Quartal des Geschäftsjahres 2025 auf Mittwoch, den 7. Mai 2025, vor der Eröffnung der NYSE festgelegt. Das Unternehmen wird um 8:30 Uhr ET eine Telefonkonferenz mit CEO Robert P. Mauch und CFO James F. Cleary veranstalten.
Die Ergebniskonferenz wird über einen Webcast auf investor.cencora.com und telefonisch zugänglich sein. Teilnehmer aus den USA und Kanada können die Nummer (833) 470-1428 wählen, während internationale Anrufer +1 (404) 975-4839 verwenden sollten, mit dem Zugangscode 962235.
Cencora, das auf Platz 10 der Fortune 500 und auf Platz 18 der Global Fortune 500 rangiert, erzielt einen jährlichen Umsatz von über 290 Milliarden Dollar. Das Unternehmen beschäftigt über 46.000 Teammitglieder weltweit und konzentriert sich auf pharmazeutische Lösungen, indem es mit Innovatoren zusammenarbeitet, um den Marktzugang für Therapien zu optimieren.
- Annual revenue exceeds $290 billion
- Strong market position: #10 on Fortune 500, #18 on Global Fortune 500
- Large global presence with 46,000+ employees
- None.
Participating in the conference call will be:
Robert P. Mauch, President & Chief Executive Officer
James F. Cleary, Executive Vice President & Chief Financial Officer
The live call will be webcast via the Company’s website at investor.cencora.com. Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call.
To access the call via telephone from within
Replays of the call will be made available via telephone and webcast. A replay of the webcast will be posted on investor.cencora.com approximately one hour after the completion of the call and will remain available for one year. The telephone replay will also be available approximately one hour after the completion of the call and will remain available for 7 days. To access the telephone replay from within
Please check the website investor.cencora.com for updates regarding the timing of the live webcasts and for replay information.
About Cencora
Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. Cencora partners with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on Cencora for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Cencora’s 46,000+ worldwide team members contribute to positive health outcomes through the power of Cencora’s purpose: Cencora is united in its responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #18 on the Global Fortune 500 with more than
View source version on businesswire.com: https://www.businesswire.com/news/home/20250328424145/en/
Bennett S. Murphy
Senior Vice President, Head of Investor Relations and Treasury
Bennett.Murphy@cencora.com
Source: Cencora